BofA: We're Upgrading Biocryst Pharmaceuticals By: Benzinga via Benzinga April 20, 2015 at 09:33 AM EDT In a report published Monday, analysts at Bank of America upgraded BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) to Neutral. The price ... Read More >> Related Stocks: Biocryst Pharma Inc